Cost-Minimization Analysis Of Anti-Tnf Biologics In The Treatment Of Rheumatoid Arthritis, Ankylosing Spondylitis And Psoriatic Arthritis Under The Brazilian Public Health Care System (Sus) Perspective
Abstract
Authors
L Scaccabarozzi